SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program
Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug companies are hungry for drug candidates to fill their pipelines. Additionally, the abundance of drug discovery contract research organizations (CROs), the ability to manage them remotely, and the ability to find partners and tools more easily on the internet presents an interesting opportunity.
Our July 19th event is our first in a series of Virtual Biotech events this year, and we’ve brought together those who have successfully outsourced drug discovery programs as well as some of the CRO providers. We’ve asked them to discuss the ‘howtos’ of managing an outsourced drug discovery project, and we think they’ll have some great insights, both at a high level and in the day to day details of the processes. In this hands-on event, we’ll take questions from you beforehand so that the resulting presentation and discussions will benefit you the most, and we’re open to what we should cover in future events. In addition, at this event some of our CRO sponsors will be providing credit for services at the event so we’re hoping you go home with some great deals for your projects. Register here.
|5:30-6:20||Networking, Dinner, Sponsor Tables||All|
|6:20-6:45||Short Sponsor Presentations||Sponsors|
|6:45-7:30||Feature Presentation: “A Tale of Two Companies: Drug Discovery’s Best and Worst of Times”||Jim Hauske, President and Founder, Sensor Pharma (Bio)|
|7:30-8:15||Outsourcing/CRO Panel||Leslie Hickle,VP, Business Development,BioAtla, LLC (LinkedIn)
Daniel Holsworth,Co-founder/Board of Directors, ODIN Therapeutics AS (LinkedIn)
Richard Lin (Moderator),President and CEO, Explora BioLabs (LinkedIn)
Ajay Madan, Senior Director of Development, Neurocrine Biosciences (LinkedIn)
Scott Struthers, Founder & CSO, Crinetics Pharmaceuticals (LinkedIn)
Diana Wetmore, Vice President of Business Development, Emerald BioStructures (Bio)
|8:15-9:00||Networking, Sponsor Tables||All|
Our generous sponsors have provided the following promotions exclusive to event attendees, come for a chance to win!
Special Event Giveaways
- Millipore: $500 credit for Select Services
- Explora BioLabs: 1 free mouse or rat small molecule pharmacokinetic (PK) study free (worth ~$3500) per standard Explora 24 hr PK design protocol (including bioanalysis).
- Imgenex: 2 additional compounds added to screen of potential inflammatory and TLR agonists or antagonists using IMGENEX TLR/NF-κB SEAPorter™ HEK 293 stable cell lines. $5,000 value.
- BioTox Sciences: a free 3 day in-life Dog PK study, up to $4,500.00 in value (not including bioanalysis).
- Emerald BioStructures: iPad! ($500 value)
- GenScript: $500 off $3000 (or $1000 off $5000) service discount on non-molecular biology services.
If you want more details on the promotions, or have a promotion to offer to attendees, or want to sponsor contact us.
Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network July 19th Event:Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program
When: Tuesday, July 19th 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25 Standard/$20 Academic/$50 Recruiter, dinner provided, cash bar
For more information about the event: http://sdbn.org/july
Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.